Barclays PLC boosted its position in shares of Anterix Inc. (NASDAQ:ATEX - Free Report) by 278.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,971 shares of the company's stock after purchasing an additional 12,484 shares during the period. Barclays PLC owned 0.09% of Anterix worth $639,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Renaissance Technologies LLC acquired a new stake in shares of Anterix during the 2nd quarter valued at about $1,334,000. Gabelli Funds LLC lifted its stake in Anterix by 4.7% in the second quarter. Gabelli Funds LLC now owns 140,422 shares of the company's stock valued at $5,559,000 after acquiring an additional 6,322 shares during the last quarter. Marshall Wace LLP lifted its stake in Anterix by 250.2% in the second quarter. Marshall Wace LLP now owns 58,652 shares of the company's stock valued at $2,322,000 after acquiring an additional 41,905 shares during the last quarter. Cubist Systematic Strategies LLC acquired a new position in shares of Anterix during the 2nd quarter worth $362,000. Finally, Squarepoint Ops LLC increased its stake in shares of Anterix by 4.6% during the 2nd quarter. Squarepoint Ops LLC now owns 26,261 shares of the company's stock worth $1,040,000 after purchasing an additional 1,159 shares during the last quarter. Hedge funds and other institutional investors own 87.67% of the company's stock.
Insider Buying and Selling
In other Anterix news, Director Leslie B. Daniels purchased 2,000 shares of the company's stock in a transaction on Wednesday, November 20th. The shares were bought at an average cost of $32.75 per share, with a total value of $65,500.00. Following the transaction, the director now directly owns 2,000 shares in the company, valued at approximately $65,500. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Mark Fleischhauer purchased 3,500 shares of the business's stock in a transaction dated Thursday, December 5th. The shares were acquired at an average price of $34.19 per share, with a total value of $119,665.00. Following the completion of the acquisition, the director now owns 3,500 shares of the company's stock, valued at approximately $119,665. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. 45.61% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Separately, Craig Hallum upgraded shares of Anterix to a "strong-buy" rating in a report on Wednesday, October 9th.
View Our Latest Analysis on Anterix
Anterix Trading Up 11.4 %
Anterix stock traded up $3.16 during trading hours on Friday, reaching $30.99. 909,858 shares of the company were exchanged, compared to its average volume of 171,260. Anterix Inc. has a 12 month low of $27.37 and a 12 month high of $42.41. The firm has a market cap of $576.97 million, a price-to-earnings ratio of -15.34 and a beta of 0.87. The stock has a 50-day moving average of $31.96 and a 200 day moving average of $35.25.
Anterix Profile
(
Free Report)
Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.
Featured Articles
Before you consider Anterix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.
While Anterix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.